share_log

榮昌生物：海外監管公告 - 第二屆董事會第十三次會議決議公告

REMEGEN: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

Hong Kong Stock Exchange ·  Apr 26 08:42
Summary by Moomoo AI
荣昌生物制药（煙台）股份有限公司於2024年4月26日召開第二屆董事會第十三次會議，會議由董事長王威東先生主持，並且全體董事均出席。會議內容包括審議通過了《2024年第一季度報告》、調整與迈百瑞及赛普生物的關聯交易上限、《2023年度環境、社會及管治報告》以及關於部分募投項目結項並將節餘募集資金永久補充流動資金的議案。所有議案均獲得出席董事一致通過。此外，公司計劃於2024年6月28日召開2023年年度股東大會。會議的召集和召開程序符合相關法律法規及公司章程的規定，會議形成的決議合法有效。
荣昌生物制药（煙台）股份有限公司於2024年4月26日召開第二屆董事會第十三次會議，會議由董事長王威東先生主持，並且全體董事均出席。會議內容包括審議通過了《2024年第一季度報告》、調整與迈百瑞及赛普生物的關聯交易上限、《2023年度環境、社會及管治報告》以及關於部分募投項目結項並將節餘募集資金永久補充流動資金的議案。所有議案均獲得出席董事一致通過。此外，公司計劃於2024年6月28日召開2023年年度股東大會。會議的召集和召開程序符合相關法律法規及公司章程的規定，會議形成的決議合法有效。
RONG CHEONG BIOPHARMACEUTICALS (YANTAI) CO., LTD. HELD THE 13TH MEETING OF THE SECOND BOARD OF DIRECTORS ON 26 APRIL 2024. THE MEETING WAS CHAIRED BY MR. WANG WEIDONG, CHAIRMAN AND ALL DIRECTORS ATTENDED. The meeting will include the discussion on the adoption of the First Quarter Report 2024, the adjustment of the cap on transactions associated with Maybury and Cyprus organisms, the 2023 Environmental, Social and Governance Report, as well as the resolutions on certain fundraising projects and permanently supplementing liquidity from the remaining fundraising funds. All resolutions were unanimously approved by the attending directors. In addition, the company plans to hold its annual general meeting on June 28, 2024, 2023. The procedure for convening and holding meetings is in accordance with the provisions of the relevant laws and regulations and the articles of association, and the decisions formed by the meeting are legally valid.
RONG CHEONG BIOPHARMACEUTICALS (YANTAI) CO., LTD. HELD THE 13TH MEETING OF THE SECOND BOARD OF DIRECTORS ON 26 APRIL 2024. THE MEETING WAS CHAIRED BY MR. WANG WEIDONG, CHAIRMAN AND ALL DIRECTORS ATTENDED. The meeting will include the discussion on the adoption of the First Quarter Report 2024, the adjustment of the cap on transactions associated with Maybury and Cyprus organisms, the 2023 Environmental, Social and Governance Report, as well as the resolutions on certain fundraising projects and permanently supplementing liquidity from the remaining fundraising funds. All resolutions were unanimously approved by the attending directors. In addition, the company plans to hold its annual general meeting on June 28, 2024, 2023. The procedure for convening and holding meetings is in accordance with the provisions of the relevant laws and regulations and the articles of association, and the decisions formed by the meeting are legally valid.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more